Income Statement (TTM)
Choong Ang Vaccine Laboratory Co., Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
|
|---|---|---|---|---|---|---|---|---|
| Revenue | 36,318 | 38,592 | 40,914 | 40,900 | 42,030 | 41,216 | 39,299 | 39,190 |
| Change (%) | 6.26 | 6.02 | -0.03 | 2.76 | -1.94 | -4.65 | -0.28 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 19,533 | 21,226 | 22,475 | 22,300 | 22,674 | 22,037 | 20,654 | 20,527 |
| Change (%) | 8.66 | 5.89 | -0.78 | 1.68 | -2.81 | -6.28 | -0.61 | |
| % of Revenue | 53.78 | 55.00 | 54.93 | 54.52 | 53.95 | 53.47 | 52.56 | 52.38 |
| Gross Operating Profit | 16,784 | 17,366 | 18,439 | 18,600 | 19,356 | 19,180 | 18,645 | 18,663 |
| Change (%) | 3.47 | 6.18 | 0.87 | 4.06 | -0.91 | -2.79 | 0.10 | |
| % of Revenue | 46.22 | 45.00 | 45.07 | 45.48 | 46.05 | 46.53 | 47.44 | 47.62 |
| SG&A | 10,420 | 11,445 | 11,421 | 11,200 | 11,913 | 11,353 | 11,824 | 12,223 |
| Change (%) | 9.84 | -0.21 | -1.94 | 6.37 | -4.70 | 4.14 | 3.38 | |
| % of Revenue | 28.69 | 29.66 | 27.92 | 27.38 | 28.34 | 27.55 | 30.09 | 31.19 |
| R&D | 1,754 | 1,766 | 1,807 | 1,685 | 1,800 | 1,852 | 1,657 | 1,545 |
| Change (%) | 0.73 | 2.29 | -6.73 | 6.82 | 2.89 | -10.51 | -6.78 | |
| % of Revenue | 4.83 | 4.58 | 4.42 | 4.12 | 4.28 | 4.49 | 4.22 | 3.94 |
| OpEx | 32,287 | 35,042 | 36,373 | 35,927 | 37,201 | 36,089 | 35,016 | 35,200 |
| Change (%) | 8.53 | 3.80 | -1.23 | 3.55 | -2.99 | -2.97 | 0.52 | |
| % of Revenue | 88.90 | 90.80 | 88.90 | 87.84 | 88.51 | 87.56 | 89.10 | 89.82 |
| Operating Income | 4,031 | 3,550 | 4,541 | 4,974 | 4,830 | 5,127 | 4,283 | 3,990 |
| Change (%) | -11.94 | 27.94 | 9.52 | -2.89 | 6.16 | -16.47 | -6.83 | |
| % of Revenue | 11.10 | 9.20 | 11.10 | 12.16 | 11.49 | 12.44 | 10.90 | 10.18 |
| Interest Expense | -94 | -84 | -110 | -158 | -201 | -211 | -242 | -272 |
| Change (%) | -10.91 | 30.89 | 44.52 | 26.54 | 4.99 | 15.00 | 12.14 | |
| % of Revenue | -0.26 | -0.22 | -0.27 | -0.39 | -0.48 | -0.51 | -0.62 | -0.69 |
| Net Income | 3,164 | 3,780 | 7,602 | 8,210 | 7,587 | 8,076 | 4,044 | 3,649 |
| Change (%) | 19.48 | 101.10 | 8.00 | -7.59 | 6.45 | -49.92 | -9.79 | |
| % of Revenue | 8.71 | 9.80 | 18.58 | 20.07 | 18.05 | 19.59 | 10.29 | 9.31 |
Source: Capital IQ
